Summary: Zinc concentrations and Cu, Zn Superoxide dismutase activity in erythrocytes were investigated in 138 healthy children and in 35 children with cancer. The mean zinc concentration in the erythrocytes of healthy children was found to be age-dependent. In the youngest group (children up to l year of age) the zinc concentration in erythrocytes is 18.8 + 3.4 μg/g Hb (5.89 + 1.23 mg/1 packed cells), which is significantly lower than in other age groups. A strong logarithmic correlation (r = 0.327, p < 0.0001 and r = 0.436, p < 0.00001) was found between age and zinc concentration in erythrocytes, expressed s μg/g Hb and s mg/1 packed red cells, respectively.
Introduction
in males, poor appetite, mental lethargy and skin Λ , .
-, , -. changes. These Symptoms were abolished by zinc supOver the years, the importance of the role of zinc m ; . //1Λ Λ ι.
· ι / -j -j LI plementation (4) . the human orgamsm has received considerable attention. In 1961, Prasad et al. (1) , indicated for the first Most of the zinc in human blood (75-88%) is found time that zinc deficiency may occur in humans. Clin-in the erythrocytes, where its concentration seems to ical manifestations of zinc deficiency were described be less variable than in plasma or serum (5) . Zinc has in the early sixties in subjects from the Middle Hast been implicated in a large number of biological func-(2, 3); these were growth retardation, hypogonadism tions, most of them involving this element s an essential component of metalloenzymes (4) . More than 200 zinc-containing enzymes are known to participate in many metabolic processes including nucleic acid, lipid and protein synthesis or degradation. The metal is present in several dehydrogenases, aldolases, peptidases, and phosphatases (4).
Ohno et al. (6) , demonstrated that 92.4% of the total zinc content of erythrocytes is present in carbonic anhydrase (87%) and Zn, Cu containing Superoxide dismutase (5.4%).
Copper and zinc-containing Superoxide dismutase (EC 1.15.1.1) catalyses the dismutation of Superoxide anions to hydrogen peroxide, thus protecting the cell against Superoxide radicals. In recent years, many publications have appeared on the subject of superoxide dismutase in malignant disease. However, the conclusions drawn have in general been based on few experimental observations, and those mainly on animal tumours (7, 8, 9) . Little is known about Cu, Zn Superoxide dismutase activity in the erythrocytes of cancer patients, and in cancer children in particular. Because abnormalities in zinc levels have been observed in association with certain malignancies (l -4), we decided to make a comprehensive study of the zinc concentration and Superoxide dismutase activity in erythrocytes of healthy children and those with cancer.
Materials and Methods

Healthy children
Zinc concentrations in erythrocytes were assayed in 138 healthy children aged 2 months-16 years (56 girls and 82 boys) from different parts of Poland, mainly from the central region. Superoxide dismutase activity in blood cells was determined in 112 children (46 girls and 66 boys). Venous blood samples for the investigation were taken from the cubital vein and placed in heparinized test tubes free from trace elements. The haematocrit and haemoglobin concentration (using Drabkin's TQagent) were determined in the whole blood. The remaining blood was centrifuged for 5 min at 5000 min~1 to remove plasma and buffy coat. Erythrocytes were washed 3 times with 9 g/l NaCl, then diluted with isotonic sodium Chloride. The haematocrit and haemoglobin were determined in the resulting erythrocyte Suspension, which was then stored at -20 °C until zinc analysis.
Cancer children
Zinc concentration and Superoxide dismutase activity were determined in two groups of cancer children.
The first group consisted of 18 children (9 girls and 9 boys) with recognized neuroblastoma. The second group included 17 children (5 girls and 12 boys) aged l-6 years, with nephroblastoma (tumour Wümsi).
In the first group, 5 children (2 girls and 3 boys) were investigated at the time of diagnosis, while a further 13 children had already previously received chemo-and radiotherapy.
Five children with nephroblastoma (l girl and 4 boys) were examined before their treatment began and 12 children (4 girls and 8 boys) were examined in the course of treatment with cytostatic pharmaceuticals or/and radiotherapy. The methods of drawing, preparation, and storage of samples for investigation were the same äs for healthy chüdren.
The zinc concentration in the red blood cells of healthy äs well äs cancer children was determined by the inethod of Agarwat et al. (15) , using a Beckman Model 1248 atomic absorption spectrophotometer with a deuterium background cprrectpr.
Zinc concentrations in erythrocytes were expressed äs g/g Hb and mg/1 packed cells.
Lyophilized Standard blood samples of the International Atomic Energy Agency (A-13) were used to monitor the äccil·-racy of zinc analysis. The mean zinc content in these samples, calculated from ten successive series of determination, was 12.5 ± 0.97 ^/g dry weight. The reference zinc value for the Standard was stated to be 13.0 g/g dry weight with 95% confidence interval (16) . The coefficient of Variation was less than 10% for red blood cells (n = 8).
Enzyme preparation and assay
The red blood cell lysate was prepäred äs described by Minami & Yoshikawa (17) .
Haemoglobin was precipitated by vigprous shaking with chlo-· roform : ethanol (l 4-2, by vol.) (18) . After centrifugation, the clear supernatant was used for Superoxide dismutase determination. Enzyme activity was measured by the spectrophotometric method (Pye Unicam SP-500 series 2 spectrophotometer) according to Misra & Fridovich (19) . The assay is based on the Inhibition by Superoxide dismutase of the Superoxide radicalmediated conversion of adrenaline to ädrenochrome in pH = 10.2 medium. The enzyme activity was calculated äs arbitrary units per mg of haemoglobin,
The data obtained were used to calculate means, Standard deviations, and correlation coefficient. Statistical significance was analysed by Studenfs t-test. Differences at p < 0.05 were considered significant.
Results
Healthy children
The results obtained in healthy children are presented in table 1. The mean zinc concentration in erythrocytes of healthy children increased with the age of the child. In the group of children up to l year of age the concentration of zinc in erythrocytes was 18.8 ± 3.4 g/g Hb (5.89 ± 1.23 mg/1 packed cells), which was significantly lower than in other age groups. From the 4th to the 7th year of age the concentration of zinc in erythrocytes was 34.9 ± 6.7 g/g Hb (11.49 ± 2.52 mg/1 packed cells) (p < 0.001 äs compared with the youngest children). The erythrocyte zinc concentration of older children showed no further ehange, attaining a value of 33.4 ± 8.24 g/g Hb at 8-16 years of age. Relationship between age and zinc concentration in 
Cancer children
The results obtained in cancer children are presented in tables 2 and 3. In the group of children with neuroblastoma no Statistical differences in zinc concentration or the enzyme activity were observed s compared with the age-matched group of healthy children (tab. 2). No significant differences in the concentration of zinc and Superoxide dismutase activity at different stages of the disease were observed (tab. 3). Differences in erythrocyte enzyme activity and zinc concentration between untreated children and children under treatment before the examination were not statistically significant. In the patients with tumour Wilmsi the measured concentration of zinc in erythrocytes was significantly higher than in the healthy age-matched group (tab. 2). The difference amounted to 16.3% (p < 0.005) g/g Hb), and 19.1% (mg/1 packed erythrocytes). The changes of zinc concentration are accompanied by significantly lowered Superoxide dismutase activity (l3.6%; p < 0.02) (tab. 2).
In the children with tumour Wilmsi a Statistically significant difference (p < 0.05) was observed in the zinc concentration in erythrocytes fag/g Hb) between the second and the third stages of the disease (tab. 3). No significant differences in the concentration of zinc or the activity of the enzyme were observed between treated and untreated nephroblastoma patients.
Discussion
The zinc concentration in human red blood cells is approximately 14 times higher than in plasma (20) . Measurements of zinc in erythrocytes may therefore be useful äs an indication of long-term zinc Status, since these cells have an average life-span of 120 days.
The data of Hihks et äl. (21) demöiistrate that approximately 90% of the blood zinc is associated with the erythrocytes, while the plasma contains 9% of the total blood zinc. Linderman et al. (22) determined the zinc concentration in erythrocytes of men and women aged 20-89 years, and found a positive linear correlation between age and zinc concentration. Other authors confirm the linear correlation between the age of the examined subjects and zinc concentration both in plasma (23) and in whole blood (5).
Contrary to the work quoted above, our results indicäte a logarithmic correlation between the age of the examined children and the concentration of zinc in erythrocytes. In our opinion, a logarithmic curve describes more accurätely the differences in zinc con<-centration in the erythrocytes of ehildren up to the third year of age, äs well äs the plateau observed at about 5-7 years (tab. l, fig. 1 ). In agreement with Linderman et äl. (22), we found nö Statistically sigr nificant sex differences in the mean erythrocyte zinc concentrations. Our investigation did not reveal äny age-dependent changes in the erythrocyte Superoxide dismutase activity öf healthy children (tab. 1). Öther authors (24) (25) (26) have reported similar cönclusiöns.
Special interest has been focused on the role of zinc in patients with malignant diseases (11, 23, 27 -29) . Few reports, however, deal with changes in the concentration of zinc in erythrocytes, while none of the available literature is addressed to the determination of zinc in the erythrocytes of children with neoplastic disease. In the present investigation, statistically significant increases in the zinc concentration of erythrocytes were accompanied by simultaneous decreases in superoxide dismutase activity in children with nephroblastoma. A similar but non-significant tendency was observed in the group of children with neuroblastoma. In the latter group the increase of zinc in erythrocytes amounted to 9% (14.3% per packed erythrocytes), whereas the enzyme activity was lowered by 9% (tab. 2). In plasma, zinc concentrations are usually low in cancer patients (11, 23, 27, 29) . Some investigators associate the lowered concentration of the element in plasma with an increased demand of the neoplastic tissue for zinc (30) . Aldor et al. (10) demonstrated a decrease of zinc concentration in plasma, whole blood and erythrocytes in patients with different forms of neoplastic disease. The decrease was significant in plasma and whole blood and non-significant in erythrocytes. The increased concentration of zinc in the erythrocytes of the examined children is difficult to Interpret. It is possibly due to ineffective erythropoiesis, in that the erythrocyte precursor normoblasts do not divide and mature normally. A similarly high erythrocyte zinc concentration is present in other clinical conditions associated with ineffective erythropoiesis (31) . The reports on Superoxide dismutase activity in neoplastic disease are not cömprehensive and, äs already mentioned, based upon examinatipn of neoplastic tissüe in aiiimals. So far, there have been few reports on Superoxide dismutase activity in human erythrocytes and in normal and pathological human cell lines. Saito et al. (32) demonstrated that Superoxide dismutase activity in the erythrocytes of stomach cancer patients was not significantly different from that of normal subjects. Morepver, Marklundtl al. (33) found no essential differences in the activity of the enzyme between normal and neoplastic cell lines. In our investigation, the observed activity of the erythrocyte enzyme was lowered by 9% in the case of neuroblastoma and by 13.7% in the case of nephroblastoma. Since a molecule of Superoxide dismutase contains atoms of two metals, copper and zinc (34) , the activity of the enzyme should depend on their concentration. However, Vilas et al. (35) did not find a relation between the concentrations of copper and zinc and Superoxide dismutase activity, either in umbilical cord blood or in the blood of neonates. In the blood of rats, on the other hand, a lowered Superoxide dismutase activity was observed äs a result of copper deficiency (36) . Copper is a part of the catalytic site of Superoxide dismutase, so its deficiency may influence the activity of the enzyme, while zinc is a structural element of enzymatic protein and in extreme cases can be replaced by other cations (37) . Hence, even considerable fluctuations in the concentration of zinc in the tissues may not cause changes in Superoxide dismutase activity.
In our opinion, not only the changes of zinc concentration in the blood of children with neoplastic disease, but also the concentration of copper should be taken into consideration. In addition, the ratio of copper to zinc, regarded äs a specific marker of neoplastic disease (11, 23, 27, 28) , should be calculated. The concentration of other elements, antagonistic to zinc should also be measured, e. g. the concentration of selenium whose role in neoplastic processes has recently been widely discussed (38) . Examination of the activity of not only Superoxide dismutase, but also of catalase and glutathione peroxidase may provide answers to many questions related to this problem. Such investigations are now in progress.
